Cancer Tests and Tumor Markers
Marker | Clinical Association |
---|---|
Alkaline phosphatase (ALP) (enzyme isozyme) | Osteogenic sarcoma, osteoblastic carcinoma metastasis |
![]() | Testicular, hepatic carcinoma |
CA 15-3 antigen (oncofetal antigen) | Breast malignancy |
CA 19-9 antigen (oncofetal antigen) | Stomach, colon, pancreatic carcinoma |
CA 50 antigen (oncofetal antigen) | Stomach, colon, pancreatic carcinoma |
CA 125 antigen (oncofetal antigen) | Ovarian, fallopian tube carcinoma |
Calcitonin (polypeptide hormone) | Thyroid medullary carcinoma |
Carcinoembryonic antigen (CEA) (oncofetal antigen) | Breast, colon, lung carcinoma |
Catecholamines (vanillylmandelic acid metabolite) | Neuroblastoma and pheochromocytoma |
Creatine kinase isoenzyme (CK-BB) (enzyme isoenzyme) | Breast, pulmonary carcinoma |
DU-PAN-2 (glycoprotein antigen) | Pancreatic carcinoma |
Galactosyltransferase (GT II) (enzyme isoenzyme) | Pancreatic carcinoma |
Genetic mutation (DNA, oncogenes) | Predisposition to development of carcinoma, leukemia, lymphoma |
Human chorionic gonadotropin (hCG) (glycoprotein hormone) | Testicular carcinoma |
5-Hydroxyindoleacetic acid (5-HIAA) (serotonin metabolite) | Carcinoid tumor |
Immunoglobulins produced by B lymphocytes | Multiple myeloma, lymphomas |
Lactate dehydrogenase (LD) (enzyme isoenzyme LD1) | Renal carcinoma, leukemia, lymphoma |
Lymphocyte B- and T-cell surface antigens (blood cell) | Lymphomas, lymphoblastic leukemia |
Neuron-specific enolase (NSE) (enolase isoenzyme) | Neuroblastoma, lung carcinoma |
Prostate-specific antigen (PSA) (serine protease) | Prostatic carcinoma |
Prostatic acid phosphatase (PAP) (enzyme isozyme) | Prostatic carcinoma |
Tissue polypeptide antigen (TPA) (oncofetal antigen) | Breast, lung, liver, pancreas, colorectal, stomach, ovary, prostate, bladder, head and neck, thyroid carcinoma |
Squamous cell carcinoma (SCC) antigen (protein antigen) | Cervical, lung, esophageal, head and neck carcinoma |
Vasoactive intestinal peptide (VIP) | Intestinal tumor |